For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

Published Date: 08 Dec 2023

Transfusion is not necessary when using iptacopan, as it outperforms C5 Inhibitors in maintaining hemoglobin levels.

Read Full News

Latest News

Definium's LSD-based Anxiety, Depression Drug Scores Another Trial Win

Definium Therapeutics said on Monday its LSD-based treatment reduced symptoms of generalized anxiety disorder ⁠in a second successful late-stage study for the...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

‘Modest’ Differences in OAT Should Not Obscure Benefits

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Alzheimer's Blood Test Gets FDA Clearance

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood ⁠test to help identify signs of Alzheimer's disease in people aged 55 and older with...

Todays Updates

Genetic Testing and Breast Cancer: Applying Guidelines and Clinical Evidence to the Identification and Management of Patients With Germline BRCA-Mutated Disease

Genetic Testing and Breast Cancer: Applying Guidelines and Clinical Evidence to the Identification and Management of Patients With Germline BRCA-Mutated Disease

Decrypting ADC Targets in PROC: Biomarker Expression, Testing, and Clinical Interpretation

Decrypting ADC Targets in PROC: Biomarker Expression, Testing, and Clinical Interpretation

Optimizing Use of Genetic Testing and Management of Care for Patients With Germline BRCA-Mutated Breast Cancer

Optimizing Use of Genetic Testing and Management of Care for Patients With Germline BRCA-Mutated Breast Cancer

FDA Expands Label of Oral HIV Drug to Newborns

Dolutegravir is already approved as combination therapy in adults and older children

Postpartum Psychosis: Who Is Most at Risk?

Disease has a continuum of severity, perinatal psychiatrist explains

U.S. Women Increasingly Not Screened for Cervical Cancer

Nearly one-third of women ages 21 to 29 had never undergone screening

These Women Face Higher Risk for Anal Sphincter Tears During Birth

Lifelong pelvic floor issues, such as incontinence, often ensue

Todays Updates

Genetic Testing and Breast Cancer: Applying Guidelines and Clinical Evidence to the Identification and Management of Patients With Germline BRCA-Mutated Disease

Genetic Testing and Breast Cancer: Applying Guidelines and Clinical Evidence to the Identification and Management of Patients With Germline BRCA-Mutated Disease

Decrypting ADC Targets in PROC: Biomarker Expression, Testing, and Clinical Interpretation

Decrypting ADC Targets in PROC: Biomarker Expression, Testing, and Clinical Interpretation

Optimizing Use of Genetic Testing and Management of Care for Patients With Germline BRCA-Mutated Breast Cancer

Optimizing Use of Genetic Testing and Management of Care for Patients With Germline BRCA-Mutated Breast Cancer

FDA Expands Label of Oral HIV Drug to Newborns

Dolutegravir is already approved as combination therapy in adults and older children

Postpartum Psychosis: Who Is Most at Risk?

Disease has a continuum of severity, perinatal psychiatrist explains

U.S. Women Increasingly Not Screened for Cervical Cancer

Nearly one-third of women ages 21 to 29 had never undergone screening

These Women Face Higher Risk for Anal Sphincter Tears During Birth

Lifelong pelvic floor issues, such as incontinence, often ensue

Latest News

Definium Therapeutics said on Monday its LSD-based treatment reduced symptoms of generalized anxiety disorder ⁠in a second successful late-stage study for the...

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

(This Aug 27 story has been republished, with no changes to text.)

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood ⁠test to help identify signs of Alzheimer's disease in people aged 55 and older with...

News All Time

Biden's Bedtime Cancer Symptom; Top Cancer Hospitals; FDA Panel to Review MCED Test

News, features, and commentary about cancer-related issues

Post-Transplant Outcomes in Hodgkin Lymphoma Improved Over Time

Improvements primarily driven by reduction in incidence of relapse

FDA Approves First CELMoD Drug for Multiple Myeloma

Iberdomide indicated as part of combination regimen for relapsed or refractory disease

Study Questions How Prostate Cancer Focal Therapy Is Being Used

Half of procedures occurred in settings not supported by guidelines

Whole Foods Recall; RFK Jr.'s Voting Problem; Glass Particles in Biosimilar

Health news and commentary gathered by MedPage Today staff

Junk Food & Prostate Cancer; 'Office' Star's Stage IV Diagnosis; New Cancer Cluster?

News, features, and commentary about cancer-related issues

Genomic Newborn Screening Could Identify Childhood Cancer Predisposition

Testing could give doctors an early start on life-preserving cancer treatments

SBRT Misses the Mark in Prostate Cancer Trial

No improvement over intensity-modulated RT in urinary symptoms after 2 years, DFS after 3 years

What Caused This Young Man's Bladder Cancer

Occupational exposure, family history make tempting hypotheses

Dramatic Increase in Active Surveillance Use for Prostate Cancer

Soared past 90% in VA system for low-risk disease, to 61% for favorable intermediate-risk disease

Melanoma Patient on Immunotherapy Develops Severe Dermatitis

Clinicians faced with presumed dermatologic AEs urged to consider all differentials

Early Sugar Exposure and Cancer Risk; Melanoma Vaccine Win; 'Antifreeze' for CAR-T

News, features, and commentary about cancer-related issues

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

US Mental Health Treatment Rates Rise But Gaps Persist

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

Recommended News For You

New Data Put ADCs on the Map in Relapsed SCLC

For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

Cancer research in the US is world class. With the government pulling out, its future is uncertain

Researchers identify a novel biomarker linked to renal cancer recurrence

From Pathology to Precision: The Story of Leukemia Therapy

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.

Recommended Articles For You

The Benefits and Side Effects of Bortezomib in the Fight Against Cancer  

Patient-Derived Response Maps for Therapy Selection: A Scientific Review 

Spatial Pharmacology Within the Tumor Microenvironment: Precision in Oncologic Therapeutics 

Hematopoietic Immune Microenvironment Plasticity: Mechanisms, Clinical Implications, and Emerging Therapeutics 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pancreatic cancer RNA vaccine shows durable T cell immunity

2.

Dostarlimab Boosts Long-Term Survival in Endometrial Cancer

3.

Exercise can counter detrimental effects of cancer treatment, review suggests

4.

In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.

5.

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

1.

Breaking Down the Benefits and Risks of Hematopoietic Stem Cell Transplantation 

2.

Targeting Oncology: Expanding Combinatorial Strategies by 2025

3.

Megakaryocyte Immune Cell Crosstalk: Mechanisms, Clinical Insights, and Therapeutic Implications

4.

How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?

5.

From Bench to Bedside: The New Era of Lymphoma Treatment and Education

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

2.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

3.

Understanding Blood Clotting Disorders

4.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

5.

Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot